David Wallace and Timothy Stocksdale co-founded Arriva Medical in Coral Springs, Fla. After its sale to diagnostic testing company Alere in Waltham, Mass., Mr. Wallace and Mr. Stocksdale remained on as Arriva’s president and vice president, respectively, from 2011-13.
The settlement, reached in the Middle District of Tennessee, settled allegations that the former executives caused Arriva to submit false claims to Medicare. The claims, according to prosecutors, involved monetary kickbacks to beneficiaries, such as free or no-cost home blood glucose meters. They also waived or didn’t collect copayments from 2011-13, according to the Justice Department. The settlement also resolves accusations that the former executives caused Arriva to bill Medicare for medically unnecessary home blood glucose meters.
In 2016, CMS revoked Arriva’s Medicare billing privileges for durable medical equipment after it shipped goods to a beneficiary more than 14 days after their death. Arriva stopped operating in late 2017.
More articles on legal and regulatory issues:
15 latest healthcare industry lawsuits, settlements
Pharmacy tech gets prison sentence for stealing $100K worth of supplies
Tulare hospital district accuses ex-board members, legal council of breaching fiduciary duties
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
